首页 | 本学科首页   官方微博 | 高级检索  
检索        

结核分枝杆菌katG、inhA、ahpC等突变与异烟肼耐药关系的研究
引用本文:彭章丽,刘梅,石亚萍,马苗苗,张建勇,张泓,陈玲.结核分枝杆菌katG、inhA、ahpC等突变与异烟肼耐药关系的研究[J].中华临床医师杂志(电子版),2013(22):31-33.
作者姓名:彭章丽  刘梅  石亚萍  马苗苗  张建勇  张泓  陈玲
作者单位:遵义医学院附属医院呼吸二科呼吸医学研究室,贵州省563003
基金项目:国家自然科学基金(81160003);贵州省省长资金临床应用课题专项研究[黔省专合字(2012)12311贵州省第五批科技创新人才团呲黔科合(2012)4011]
摘    要:目的:了解结核分枝杆菌katG、inhA、ahpC、fabG1、sodA及sodC基因突变的特征及其与耐异烟肼的关系。方法对127例活动性肺结核患者痰标本进行菌型鉴定及结核分枝杆菌药敏试验,提取结核分枝杆菌菌株DNA,应用PCR扩增katG、inhA及ahpC、fabG1、sodA及sodC基因片段,并进行DNA序列分析。结果结核分枝杆菌药物敏感试验显示127株结核分枝杆菌中,其中47株耐异烟肼,80株对异烟肼敏感,耐异烟肼率为37.01%。47株耐异烟肼中,29株存在katG和(或)inhA基因突变,其中22株(46.81%,22/47)存在katG基因单位点突变,3株(6.38%,3/47)存在inhA基因单位点突变,4株(8.51%,4/47)存在katG及inhA基因联合位点突变。22株katG基因单位点突变中,20株为AGC315ACC、AGC315AAC (42.55%,20/47)突变,2株(2.13%,1/47)分别为CTG378CCG(Leu378Pro)、ACG394ATG(Thr394Met)突变,该突变位点及突变形式尚未见文献报道。18株katG及inhA未突变结核分枝杆菌均未检测到ahpC、fabG1、sodA及sodC基因突变。结论结核分枝杆菌对异烟肼耐药主要与katG和inhA基因突变有关。耐异烟肼结核分枝杆菌临床分离株378和394新突变位点的发现为进一步研究耐药机制以及耐药结核病的快速检测提供了依据。

关 键 词:分枝杆菌,结核  异烟肼  突变  katG  inhA

The relationship between mutations in katG,inhA, ahpC and other genes of Mycobacterium tuberculosis and isoniazid resistance
PENG Zhang-li,LIU Mei,SHI Ya-ping,MA Miao-miao,ZHANG Jian-yong,ZHANG Hong,CHEN Ling.The relationship between mutations in katG,inhA, ahpC and other genes of Mycobacterium tuberculosis and isoniazid resistance[J].Chinese Journal of Clinicians(Electronic Version),2013(22):31-33.
Authors:PENG Zhang-li  LIU Mei  SHI Ya-ping  MA Miao-miao  ZHANG Jian-yong  ZHANG Hong  CHEN Ling
Institution:. Laboratory of Respiratory Medicine, Second Department of Respiratory Medicine, Affiliated Hospital of Zunvi Medical College, Zunyi 563003, China
Abstract:Objective To understand the relationship between characteristics of mutations in katG, inhA, ahpC, fabG1, sodA, and sodC genes of Mycobacterium tuberculosis and isoniazid (INH) resistance. Methods A total of 127 Mycobacterium tuberculosis clinical isolates from sputum of patients with active pulmonary tuberculosis were collected and used for mycobacterium species identification, drug susceptibility testing and extraction of genomic DNA. DNA fragments specific for katG, inhA, ahpC, fabG1, sodA and sodC genes were amplified by PCR and used for sequence analysis and comparison with the standard laboratory strains (H37RV) through the use of NCBI database. Results Out of 127 clinical isolates tested for INH susceptibility, 47 (37.01%) were resistant and 80 were susceptible to INH. Among 47 INH-resistant isolates, 29 had mutations in katG and/or inhA genes, 22 (46.81%, 22/47) had point mutation in katG gene, 3 (6.38%, 3/47) had mutation in the promoter region of inhA gene, and 4 (8.51%, 4/47) had point mutations in both katG and inhA genes. Among 22 isolates with mutation in katG gene, 20 (42.55%, 20/47) had mutation at codon 315 (AGC315ACC or AGC315AAC) and 2 (2.13%, 1/47) had mutation at codons 378 (CTG378CCG, Leu378Pro) and 394 (ACG394ACC, Thr394Met). In 18 isolates without mutations in katG and inhA genes, no mutation was detected in ahpC, fabG1, sodA and sodC genes. Conclusion Results from this study further confirm that mutations in katG and inhA genes of Mycobacterium tuberculosis are associated with isoniazid resistance. Two new point mutations in the katG gene have been identified from the study, which will provide new information for further development of quick diagnostic methods for drug-resistant tuberculosis.
Keywords:Mycobacterium tuberculosis  Isoniazid  Mutation  katG  inhA
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号